ASX-listed Creso Pharma has won a US$625k order from Univo Pharmaceuticals to export its premium cannabis strains to Israel.
The order is the second from Univo this year and gives Creso the opportunity to leverage the medicinal cannabis company’s extensive Israeli distribution network. Univo has licenses for the entire supply chain including cultivation, production, R&D and distribution.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.